cysteamine has been researched along with Nervous System Disorders in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, SI; Clayton, PA; McTaggart, SJ; Spicer, RA; Zhang, GY | 1 |
| Ariceta, G; Camacho, JA; Fernández-Obispo, M; Fernández-Polo, A; Gamez, J; García-Villoria, J; Güell, A; Lara Monteczuma, E; Leyes, P; Martín-Begué, N; Morell, GP; Oppenheimer, F; Perelló, M; Santandreu, AV; Torra, R | 1 |
| Antignac, C; Brodin-Sartorius, A; Charbit, M; Cochat, P; Guest, G; Legendre, C; Lesavre, P; Moyse, D; Niaudet, P; Ottolenghi, C; Servais, A; Tête, MJ | 1 |
| Hasegawa, E; Murai, Y; Oishi, T | 1 |
| Mydlarski, MB; Schipper, HM; Wang, X | 1 |
| Ohno, K | 1 |
1 review(s) available for cysteamine and Nervous System Disorders
| Article | Year |
|---|---|
[Cystinosis].
Topics: Amino Acid Transport Systems, Neutral; Cysteamine; Cystinosis; Diagnosis, Differential; Gene Deletion; Genes, Recessive; Glycoproteins; Humans; Membrane Proteins; Membrane Transport Proteins; Nervous System Diseases | 2000 |
5 other study(ies) available for cysteamine and Nervous System Disorders
| Article | Year |
|---|---|
Patient and graft survival following kidney transplantation in recipients with cystinosis: a cohort study.
Topics: Adult; Australia; Cause of Death; Cohort Studies; Cysteamine; Cystine Depleting Agents; Cystinosis; Female; Graft Survival; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Nervous System Diseases; Patient Outcome Assessment; Survival Analysis; Vascular Diseases | 2015 |
Cystinosis in adult and adolescent patients: Recommendations for the comprehensive care of cystinosis.
Topics: Adolescent; Adult; Amino Acid Transport Systems, Neutral; Comprehensive Health Care; Corneal Diseases; Cysteamine; Cystinosis; Disease Management; Early Diagnosis; Endocrine System Diseases; Genetic Counseling; Humans; Interdisciplinary Communication; Kidney Failure, Chronic; Kidney Transplantation; Nervous System Diseases; Patient Education as Topic; Quality of Life; Self Care; Transition to Adult Care | 2015 |
Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults.
Topics: Adolescent; Adult; Age Factors; Amino Acid Transport Systems, Neutral; Child; Child, Preschool; Cysteamine; Cystinosis; Diabetes Complications; Disease Progression; Educational Status; Employment; Fanconi Syndrome; Female; Follow-Up Studies; Humans; Hypothyroidism; Infant; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Nephrotic Syndrome; Nervous System Diseases; Neuromuscular Diseases; Radiation-Protective Agents; Young Adult | 2012 |
Sulfhydryl drugs reduce neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Cysteamine; Dimercaprol; Dopamine; Dopamine Agents; Glutathione; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Nerve Degeneration; Nervous System Diseases; Pyridinium Compounds; Sulfhydryl Compounds | 1993 |
Cysteamine gliopathy in situ: a cellular stress model for the biogenesis of astrocytic inclusions.
Topics: Animals; Astrocytes; Cysteamine; Cytoplasmic Granules; Heat-Shock Proteins; Immunohistochemistry; Male; Nervous System Diseases; Neuroglia; Peroxidase; Rats; Rats, Sprague-Dawley; Stress, Physiological | 1993 |